Syntese
Manufacturing · Denmark · 51-200 Employees
View Company Info for Free
Overview
Headquarters
Industriholmen 11-13, Hvidovre, Capital ...Phone Number
+45 36340030Website
www.syntese.dkRevenue
$7 MillionIndustry
About Syntese
Is Syntese your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Syntese recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Congratulate Masked Content for being promoted to Masked Content at Syntese
Check out if Syntese is spiking on competitors!
Product Launch: Get notified when Syntese launches new products
Check if Syntese has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Funding: Get notified immidiatlly once Syntese has new funding data
Click to see if Syntese had a recent Job posting/layoffs
Syntese, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at Syntese
Find 3 more new buyers
Company Profile Activity
Activity Insights
Syntese is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Syntese is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Syntese.
Syntese Tech Stack
A closer look at the technologies used by Syntese
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Syntese
Syntese A/S, a subsidiary of Ferring, specializes in the manufacturing of mesalazine, a key pharmaceutical ingredient used in treatments for ulcerative colitis and Crohn's disease. With over 40 years of experience, the company is dedicated to improving the quality of life for patients suffering from inflammatory bowel diseases. Syntese fosters a co... Read More